EW: Edwards Lifesciences Inc. Price to Earnings Adjusted for Growth Rate
Risks for Edwards Lifesciences (EW) are linked to a narrow implant portfolio and regulatory delays. High margins are supported by flawless heart valve logistics and a network of laboratories. An aging population guarantees demand, although success depends on the implementation of minimally invasive methods. The valuation-to-growth ratio demonstrates the price-to-earnings dynamics, where the latest mark stands at 2.19.
Analytical breakdowns for Edwards Lifesciences (EW)
- share price and expert price forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Edwards Lifesciences|EW - Long-Term Debt to Capital|Current Liabilities to Capital edwards.com|EW - Company Aggregate Debts|Debt to Book Value Ratio Edwards Lifesciences Corp|EW - Company Long-Term Debts|Short-Term Debt Volume Edwards Lifesciences|Quick Liquidity Indicator edwards.com
- net income and valuation multiples indicators:
EW - Net Profit|Projected Future Earnings Edwards Lifesciences|EW - Price to Earnings Ratio|Future Price to Earnings Edwards Lifesciences Inc.|EW - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Edwards Lifesciences Corp|EW - Operating profit EBITDA|Net earnings per one share for the last twelve months Edwards Lifesciences|EW - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year edwards.com|EW - Net earnings per share growth this year|Earnings growth forecast for next year Edwards Lifesciences
General company analysis:Edwards (EW)
Edwards Lifesciences dominance in the Sapien transcatheter valve segment ensures a stable cash flow and high operational efficiency. Analyzing the ratio of cost to business expansion rates, the investor assesses the balance between the share price and the speed of profit growth: values below one signal a fundamental undervaluation of the asset relative to its development dynamics.
Competing companies
BSX: Market Cap to Earnings and Growth Ratio|PEG Multiple RMD (ResMed Corp)|Insulet Inc. (PODD) - Price to Earnings Adjusted for Growth Rate|Zimmer Biomet Holdings, Inc. - PEG Multiple|COO (coopercos.com) - Growth-Adjusted P/E Ratio|ALGN (Align Technology) - Price/Earnings to Growth Multiple|Globus Medical Inc - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio TransMedics Group|Price/Earnings to Growth Multiple Alphatec Corp (ATEC)|PEG Multiple AORT|ENOV - Price to Earnings Adjusted for Growth Rate|PEG Multiple IART (Integra LifeSciences Holdings Corporation)|ESTA: Growth-Adjusted P/E Ratio|Beta Bionics Corp - PEG Multiple|Growth-Adjusted Market Cap to Net Income IRADIMED Inc. IRMD|EMBC: PEG Multiple|Price/Earnings to Growth Multiple tandemdiabetes.com|AXGN (Axogen) - PEG Multiple|PEG Multiple SI-BONE Inc|Price/Earnings to Growth Ratio Orthofix International (OFIX)|Price/Earnings to Growth Ratio BVS (Bioventus Global)|OrthoPediatrics - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio TMCI|Strata Critical Medical - PEG Multiple|Price to Earnings Adjusted for Growth Rate Carlsmed, Inc.|RxSight Corp (RXST) - Price/Earnings to Growth Ratio|Price to Net Income Growth Ratio ClearPoint Neuro CLPT|Price/Earnings to Growth Multiple STXS|PEG Multiple neurostar.com|PEG Multiple SGHT|Growth-Adjusted Market Cap to Net Income Orchestra BioMed Inc.|Price/Earnings to Growth Ratio Anika Therapeutics, Inc. ANIK|NSPR (InspireMD Inc.) - Market Cap to Earnings and Growth Ratio|ZJYL - Price/Earnings to Growth Ratio|Vivani Medical, Inc. (VANI) - Price/Earnings to Growth Multiple|XTNT: PEG Multiple|Price to Earnings Adjusted for Growth Rate NeuroOne (NMTC)|Price/Earnings to Growth Ratio Modular Medical Inc|Growth-Adjusted P/E Ratio MYO (Myomo Inc)|Price/Earnings to Growth Multiple COCH (Envoy Medical, Inc.)|Company Value to Earnings Growth Ratio VVOS|PEG Multiple NVNO (enVVeno Medical Corp.)|Sintx Technologies Inc (SINT) - Price to Earnings Adjusted for Growth Rate|Tenon Medical, Inc - PEG Multiple|LFWD (Lifeward Ltd.) - Growth-Adjusted P/E Ratio|AMIX (autonomix.com) - Price/Earnings to Growth Multiple|Price/Earnings to Growth Multiple invobioscience.com|BBLG (Bone Biologics Corp) - PEG Multiple|PEG Multiple Axonics Inc.|Price/Earnings to Growth Ratio Biolase, Inc. (BIOL)|DYNT (dynatronics.com) - Growth-Adjusted Payback Ratio|PEG Multiple FNA (Paragon 28)|INVO: Growth-Adjusted P/E Ratio
